The present clinical trial clarified that basic fibroblast growth factor-2 (FGF-2) can induce regeneration of periodontal tissue lost by progression of periodontitis and evaluated the safety of such induction.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
91
rate of increase in alveolar bone height
Time frame: 36 weeks after administration
clinical attachment level (CAL) regained
Time frame: 36 weeks after administration
time course of rate of increase in alveolar bone height
Time frame: within 36 weeks after administration
time course of CAL regained
Time frame: within 36 weeks after administration
the other periodontal inspections (PD, BOP, GI etc.)
Time frame: within 36 weeks after administration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.